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The 1.5 A˚ Crystal Structure of a Highly Selected
Antiviral T Cell Receptor Provides Evidence
for a Structural Basis of Immunodominance
choice of unique TcRs, biased selection of TcRs occurs
in some viral infections [4–11], autoimmunity [12], and
in certain alloreactive responses, such as the anti-RT1f
response in allogeneic rats [13]. In addition germline
specificities inherent in some TcR V regions [9, 13] prob-
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The simultaneous focus of TcR interactions with hostAustralia
MHC molecules and fragments of foreign antigen is
unique in receptor-ligand interactions and has recently
been illuminated in structures of  TcR heterodimersSummary
in complex with MHC-peptide (MHC-P) complexes or
other structures [18–30]. There are only five examples ofDespite a potential repertoire of1015  T cell recep-
tors (TcR), the HLA B8-restricted cytolytic T cell re- complete heterodimeric extracellular  TcR structures:
two murine TcR structures, termed 2C [18] and N15 [22],sponse to a latent antigen of Epstein-Barr virus (EBV)
is strikingly limited in the TcR sequences that are se- and three human structures, termed A6 [19, 26], B7 [26],
and HA1.7 [25]—none of which represent naturally se-lected. Even in unrelated individuals this response is
dominated by a single highly restricted TcR clonotype lected TcRs containing highly restricted VDJ and VJ
sequences. As predicted [1], the TcR resembles an anti-that selects identical combinations of hypervariable
V, V, D, J, and N region genes. We have determined body Fab, with the  heterodimer adopting four Ig-like
folds with a variable (V) and constant (C) domain in eachthe 1.5 A˚ crystal structure of this “public” TcR, reveal-
ing that five of the six hypervariable loops adopt novel chain [2, 18, 23, 31, 32]. The antigen recognition site of
the TcR is made up of six hypervariable regions, threeconformations providing a unique combining site that
contains a deep pocket predicted to overlay the HLA each from the V and V domain, and these are termed
complementarity-determining regions (CDRs 1, 2, andB8-peptide complex. The findings suggest a structural
basis for the immunodominance of this clonotype in 3). Canonical CDR structures are now being recognized,
but the database of structures is not sufficient to definethe immune response to EBV.
all of these at present, and their generality has not been
confirmed [33].Introduction
The small number of available TcR structures and their
varying resolutions (maximum of 2.5 A˚) does not yetT lymphocytes determine the specificity of immune re-
sponses through their clonally distributed antigen re- provide us with a refined perspective of the structural
principles that determine TcR assembly, selection ofceptors (TcRs) [1, 2]. The majority of T cells express
heterodimeric, disulphide-bonded  receptors that particular V/V combinations, repertoire of CDR struc-
tures, modes of cognate interaction with MHC-P, andcorecognize structural determinants on microbial pep-
tides complexed with products of the major histocom- mechanisms of alloreactivity. Therefore, we have under-
taken the study of a public T cell receptor from a humanpatibility complex (MHC) [1]. In order to cope with the
huge number of foreign peptides that might be pre- CTL clone with dual specificity for a cognate antiviral
ligand and an allogeneic HLA molecule. The CTL clone,sented by polymorphic MHC molecules, a vast TcR rep-
ertoire is generated from sequential, but random, re- LC13, specifically, recognizes HLA B8 in complex with
the FLRGRAYGL peptide determinant from EBNA 3, aarrangements involving 40–48 functional V genes, 2
D genes, and 12–13 J genetic segments [1]. This is latent Epstein Barr virus (EBV) antigen. EBV is a ubiqui-
tous member of the Herpes virus family and establishesfollowed by rearrangement of any 1 of 44–46 functional
V genes with 1 of 50 J gene segments. Further a persistent infection in up to 90% of adults. The LC13
TcR comprises highly restricted VJ (AV4S1/AJ14S3,receptor diversity is generated through untemplated N
region additions, deletions at VDJ and VJ junctions, and or TRAV26-2*01; TRAJ52*01) and VDJ (BV6S2/BD/
BJ2S7, or TRBV7-8*03; TRBD1*01; TRBJ2-7*01) genediverse  combinations giving 1015 TcRs with poten-
tially unique specificities. Thymic selection results in a segments. These same gene segments, including highly
selected junctional N region additions, are found in theresidual repertoire of 107 –108 unique TcRs [3] able to
recognize diverse foreign antigens. Despite this vast same combination in most CTL specific for B8/
FLRGRAYGL from unrelated individuals [5, 8], and this
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specificity can comprise up to 10% of circulating CD8
T cells [8, 34, 35]. Hence, the LC13 clonotype is referred
to as a public TcR [5]. This conserved receptor usage
and the selection of virtually identical N region se-
quences are remarkable, given the potentially enormous
repertoire of unique T cell receptors. CTL expressing this
TcR also recognize allogeneic HLA B*4402 and B*4405
class I molecules [36, 37], making its structure of even
greater interest. In order to determine the structural con-
tribution of the highly selected LC13 residues and to
further understand the basis of the immunodominance
and overselection of this TcR archetype, we have solved
the crystal structure of the heterodimeric  LC13 re-
ceptor.
Results
The High-Resolution Structure
The extracellular domains of the LC13 TCR were ex-
pressed in E.coli and refolded to generate a soluble form
of the LC13 receptor suitable for structural determina-
tion. The LC13 TcR was then crystallized, and the struc-
ture was determined to 1.5 A˚ resolution. The LC13 struc-
ture comprises four immunoglobulin (Ig)-like domains,
with a variable (V) and constant (C) domain in each chain
(Figures 1, 2A, and 2B). The interface between the LC13
 and  chain is extensive (4000 A˚2 of buried surface Figure 1. Structure of the LC13  TcR
area), with the V and the C domains packing against Ribbon representation showing the  chain and the  chain colored
each other. The buried area of 1400 A˚2 within the LC13 red and blue, respectively, with the variable domains colored in a
lighter shade. The hypervariable loops, located within the V domains,V-V interface is less extensive than that of the human
are at the “top” of the molecule, and the C domains are membraneA6 (1600 A˚2 ), B7 (1480 A˚2 ), or HA 1.7 (1440 A˚2 ) [19, 25,
proximal. The three CDR regions and the HV4 region of each chain26] and the mouse D10 (1900A˚2 ) [28, 38], 2C (1450 A˚2 ), or
are numbered. The secondary structure labeling is done according
N15 (1500 A˚2 ) [18, 22]. to previously established nomenclature. The residue numbering is
The overall structure of the LC13 TcR is similar to done according to the numbering in the human B7 structure. Sec-
previously determined TcR structures (Figures 1,2A, and ondary structure assignments (determined with PROMOTIF [56]) for
the V domain are as follows: residues 3–4, a; 9–13, a; 18–24, b;2B). The comparative analyses will largely be restricted
32–37, c; 44–49, c; 55–56, c″; 62–66, d; 72–77, e; 86–91, f ; 110–115,to the intact heterodimeric TcR crystal structures,
g. Those for the V domain are as follows: residues 5–7, a; 10–14,namely, three human (A6, B7, and HA1.7) [19, 25, 26]
a; 19–24, b; 31–37, c; 44–50, c; 53–56, c″; 65–68, d; 75–79, e; 88–95,
and two murine (2C and N15) [18, 22] TcRs. The rms f; 107–108, g; 112–117, g.
deviations for the pairwise superpositions between
LC13 and 2C, A6, B7, N15, and HA1.7 are 1.42 A˚ (387
residues), 1.41 A˚ (416 residues), 1.41 A˚ (413 residues), V and C domains (840 A˚2 of buried surface area)
appear to be more intimate than those between their1.65 A˚ (373 residues), and 1.81 A˚ (395 residues), respec-
tively (calculated over the entire heterodimer with 2C counterparts (560 A˚2 of buried surface area), and
this may be due, in part, to the absence of a bulkyLSQMAN [39]). For a breakdown of the individual do-
main/domain superpositions, see the Supplementary Trp82 residue, which appears to push the domains
apart in the 2C crystal structure. This allows LC13Material available online with this article. The differences
between the LC13 and the five other TcR structures Glu14 to make a salt bridge with Lys174, whereas the
corresponding 2C Glu14 is too distant to interact.relate to a different quaternary structure as well as some
elements of tertiary structure unique to LC13. In some The high-resolution structure also highlighted the sig-
nificant role water molecules play not only at the interdo-structures the C domain was initially too disordered to
model or had shown a moderate to high degree of mobil- main interfaces, but also at the combining site. MHC
binding, TcR conformational changes upon MHC bind-ity [18, 19, 26]. However the C domain of the LC13
structure was highly ordered (Figure 2A), suggesting that ing, and coreceptor binding will each result in displace-
ment of a significant number of these water molecules.neither an intact C-terminal interchain disulfide bond nor
carbohydrate residues are essential for C stability and
structure [26]. In addition the stability of the LC13 C The C Domain: Of Mice and Men
Despite the high level of sequence identity (48%) betweendomain appears not to be a result of crystal contacts,
as the only C region mediating such contacts involves the human and murine C domains, there are several
structural differences that have not previously beenresidues 201–207. This suggests a feature inherent in
the LC13 TcR V domains that may stabilize the C do- noted between these domains (Figures 3A and 3B).
The human LC13 TcR contains a significant electro-main. For example, the interactions between the LC13
T Cell Receptor Structure and Immunodominance
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Figure 2. Stereo Views of the LC13 TcR Het-
erodimer
(A) Stereo view of the LC13 C trace, colored
according to a temperature factor ramping,
where blue corresponds to a low temperature
factor (10 A˚2 or less) and red corresponds to
a high temperature factor (50 A˚2 ). The average
temperature factor per domain is as follows:
V, 22.5 A˚2; C, 23.7 A˚2; V, 17.7 A˚2 ; C,
20.1 A˚2.
(B) Stereo view of the V domains, looking
down onto the hypervariable loops. The V
CDR1, 2, and 3 loops are color-coded red,
magenta, and blue, respectively. The V
CDR1, 2, and 3 loops are color-coded green,
light blue, and yellow, respectively.
negative patch located on the surface of the C domain would impact on the electrostatics of the C domain), is
that, in the murine structure, Lys 140 (the equivalentmeasuring approximately 25 A˚ by 12 A˚ and extending
from the tip of the V domain (Glu14, Glu15, and residue in LC13 is a Thr) forms salt bridges with Asp
145 and Asp 122, thereby negating the charge of theGlu16) (this acidic feature is not present in the murine
structure) to the C-terminal tail (Figure 3A). Apart from acidic residues. A patch of such magnitude in LC13 is
suggestive of a functional role and possibly representsresidues Glu200 and Asp201, the murine TcRs also
have acidic residues at these same positions in the C a site of interaction with a TcR signaling component or
a coreceptor [40], such as the highly basic CD3 subunit.domain, but this does not result in the same electrostatic
surface observed for human C (Figure 3B). One possi- This notion is consistent with the reactivity of the anti-
TcR mAb H28-710, which only recognizes this part ofble reason for such a difference, besides the constella-
tion of charged residues at the tip of the V domain (that the murine C in the absence of CD3 components [41].
Figure 3. Electrostatic Surface Potential
Comparison between Human and Mouse TcR
Structures
Red and blue indicates electronegative and
electropositive potential, respectively.
(A) Highlighting the electronegative patch on
the LC13 C domain.
(B) The corresponding area in the 2C TcR
[21]. Electrostatics calculations and surface
generation were calculated by standard pro-
cedures as implemented in GRASP.
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However, the differences in charge potential of the mu-
rine and human C surfaces may imply that the two
species have adopted different strategies for using this
region of the receptor.
The unusual topology of the C domain, first de-
scribed in the 2C TcR [18, 21], is confirmed in the high-
resolution LC13 structure (Figures 1 and 2A). The overall
rmsd is 1.35 A˚2 (71 equivalent residues), with the major
structural differences residing in the a-b loop, the d-e
loop, and residues of the C-terminal tail (194–207). Gar-
cia and colleagues [18] noted that the top “strands” were
loosely packed against the bottom  sheet, resulting in
exposure of some of the hydrophobic interior of the
bottom sheet to solvent. In the LC13 structure, the loop
connecting the minihelix (residues 189–193) to the g
strand (residues 202–203) is five residues longer than
Figure 4. Structural Landscape of LC13 Complementarity-Deter-
the murine TcR. This ten-residue loop makes a number mining Regions
of polar and van der Waals contacts with the main chain
Superposition of the V domains of LC13 and 2C, in a worm represen-
of the c strand: the side chains of Asn195O1 and tation. The LC13 CDR regions are color-coded as in Figure 2B. The
Ser196O hydrogen bond to the main chain of Gln152O CDR regions of 2C are shown in orange
and Ser151N, respectively. There are four water-medi-
ated hydrogen bonds between these two elements of
secondary structure: Ile197N bonds to Asn1590 and suggestive that the hydrophobic interactions are the
Ser151O, Ile197O bonds to Asn149N, and Ile1970 major driving force in the CC dimerization in an analo-
bonds to Thr148O. In addition, Ile198 makes van der gous manner to the VV interface.
Waals contacts with Phe141 and Thr148, and
Pro199 packs against Thr148 and Pro123. The over-
The Variable Domainsall consequence of these interactions is that the hy-
The pairwise sequence identity between LC13 and thedrophobic interior of the human C domain is less ex-
previously determined TcR structures range from 20%–posed to the bulk solvent in comparison with the murine
25% and 32%–47% in the V and the V domains, re-counterpart.
spectively. Despite this overall low level of sequenceThe extensive LC13 C/C interface (2600 A˚2 ) is
identity, the structures of the V domains are similar,primarily composed of the back  sheets of both do-
confirming the unusual topology of the V domain. Themains abutting against each other, forming a central
major structural differences between the LC13 and thehydrophobic core that is well conserved between the
other structures reside in the hypervariable loops andmurine and human TcRs (see the Supplementary Mate-
the loop (69–74) adjacent to the combining site (Figurerial). The LC13 interface is further extended, however,
4; see the Supplementary Material). The VC interdo-via the a-b and d-e loops from the C domain that
main angle appears to be relatively fixed; however, therecollectively clamp around both ends of the C domain
is varied disposition of the V/V interdomain pairing, sheet. These flanking regions of the LC13 C domain
resulting in unique features within the respective inter-interact predominantly via polar residues with the C
faces (see the Supplementary Material). For example, adomain. The conformations of the LC13 a-b and d-e
rotation of 16.3 is required to superimpose the equiva-loops are different to the corresponding 2C loops, and,
lent V domains of LC13 and N15. Since the relativeas a result, the polar interdomain interactions are mark-
orientation within the V/V pairing is critical in de-edly different. The LC13 a-b loop folds back toward
termining what residues contact the MHC-peptide com-the  sheet of the C domain, allowing water-mediated
plex, this reflects considerable plasticity in the TcR li-interactions to occur, whereas the murine a-b loop is
gand binding site.more distant from the C domain, and, as a result, this
The VV interface is composed of the f-g and theloop does not form interdomain interactions. Briefly, of
c-c strands and their interconnecting loops from eachthe 9 polar interactions within the 2C CC interface
domain crossing over each other (Figure 1; see the Sup-and the 27 polar interactions at the LC13 interface, there
plementary Material). The CD3 loop overhangs theare only 3 strictly conserved polar interactions (Asp145→
CDR3 loop, which sits centrally within the interface. OfArg198, Thr164→ Ser174, and Asp167→ Gly172)
the approximately 1400 A˚2 of buried interface, there areand 2 structurally equivalent interactions (122→ 140
nine polar interactions, 11 V residues participating inand 129→ 131) between the structures. Despite some
water-mediated contacts, and a multitude of van deridentical polar residues at equivalent positions at the
Waals interactions. A dominant feature of the V/VCC interface between both species, the human
interface is the rich and extensive cluster of aromaticTyr126 and Arg196 do not participate in the interdo-
residues (Tyr35, Tyr45, Tyr89, Tyr100, Phe106,main interactions observed in the murine counterparts.
Phe33, Tyr35, Phe45, and Tyr48), which is largelyGiven the fixed CC interdomain angle between the
conserved in the other TcR structures. However, theremurine and human TcRs (a maximal rotation of 4.7 be-
are only two polar interactions that are strictly conservedtween LC13 and N15), the conserved hydrophobic inter-
actions, and the more varied polar interactions, it is between the TcR structures: (1) the Gln37/Gln37 hy-
T Cell Receptor Structure and Immunodominance
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drogen bond and (2) the Tyr35 hydrogen bonding onto of Leu50 hydrogen bonds to Arg70N	1 and forms a
water-mediated contact with Gly29O. Thr51 o1 hydro-the backbone of Gln106.
gen bonds to Ser52O and to Leu50N via two bridging
water molecules. Ser52O hydrogen bonds to Ile66N,
Structure of the Complementarity-Determining and the main chain of the solvent-accessible Asn54
Regions and the LC13 Ligand Binding Site hydrogen bonds to framework side chain Asn56O1.
As anticipated, the structural landscape of the LC13 CDR1 comprises residues 25–32 and, unlike CDR1,
antigen combining site is significantly different to the CDR1 makes a number of contacts with CDR3 as
previously determined TcR structures (Figure 4). More- well as with residues from CDR2 (Figures 2B and 5C).
over, the structure of LC13 reveals the important role CDR1 adopts a similar conformation and has similar
water molecules play in mediating the contacts between framework residues to the 1-2 canonical class (Pro25,
the CDR loops. In addition two residues within the CDR His29, and Leu32). Pro25 packs against Leu32,
loops (Leu50 and Ser95) adopt alternate conforma- Ser73, and Ser94 (Figure 5C). Residues 26–29 adopt
tions, suggesting flexibility in this region of the receptor a type II  turn, with Ile26 making van der Waals con-
[28, 38]. tacts with Tyr107 and His29. A glycine links the sol-
The existence of canonical CDR conformations in vent-exposed Ser27 and His29, the point at which
TcRs was previously predicted [42] and confirmed by the CDR2 loop folds back into the framework. This
the crystal structure determination of a subset of TcRs. histidine hydrogen bonds to Ser94O. Val30 makes
More recent analyses suggest that, for the CDR1 and van der Waals contacts with Asn51 and Leu96, while
CDR2 regions, close to 70% of the V segments and Val30O hydrogen bonds to the main chain nitrogen of
90% of the V segments have hypervariable regions Asn51N. Ser31O hydrogen bonds to Tyr48O	 and
that adopt a conformation of one of the known canonical makes contacts (via a water molecule) with Tyr100O.
structures [33]. The accuracy of predicting CDR3 canon- CDR2 comprises residues 49–54 and adopts a type
ical structures, however, is complicated by their greater II  turn (residues 50–53) and a  bulge (type AW) 49/
variability and length. Thus, it is of considerable interest 54/55, which together form a nonextended CDR loop
that the CDR1 and CDR2 of the V domain and CDR2 conformation (Figure 5D). This loop is similar to, but
of the V domains of LC13 adopt conformations that distinct from, the 2-2 canonical class (Figure 6). The
are different from previously described canonical CDR main chain of Phe49O,N hydrogen bonds to Leu32O,N,
conformations [33] (Figures 5A–5D and 6). The structure while the side chain packs inside the loop, sandwiched
of each CDR loop is shown (Figures 5A–5D and 6) and between the long side chains of Gln54 and Arg69,
is described in detail below. and additionally contacts Leu32 and Trp34. The side
CDR1 comprises nine residues (24–32) and adopts chains of Gln50, Asn51, Glu52, and Ala53 at the
a conformation that is very different from that predicted tip of the CDR2 are solvent exposed and make limited
or reported in other TcR structures (Figures 5A and 6). contacts with neighboring residues (Figure 5D). The
The flat and extended conformation of CDR1 is approx- main chain of Asn51 forms hydrogen bonds with
imately 17 A˚ in length, and, unlike previously reported Val30O and Arg69N	1. Gln54 points inward, toward
structures, it does not form contacts with CDR3 (Fig- the framework residues, with its side chain hydrogen
ures 2B and 4). Instead, the loop folds back and packs bonding to Thr47 o1 and Ala67O.
against CDR2 and the backbone of the c″-d loop (resi-
dues 69–73), including the side chain of Arg70. Resi-
dues 25–27 adopt no secondary structure, but the con- Structural Basis of Public Sequence Conservation
The  Chainformation of the loop is restrained by His24 and the
c″-d loop. His24 forms van der Waals interactions with The highly conserved public sequences of the LC13 TcR
comprises residues 88–116 encoded by the VJN regionIle27 and Ile32, while the side chain His24N1,N
1 forms
hydrogen bonds with Ser25O and Ser73o (Figure 5A). of the  chain and includes the CDR3 loop (Figure 7).
The conserved V region (residues 88–91) is locatedThe side chains of Ser25, Thr26, and Thr30 are sol-
vent exposed, whereas Ile27 points in toward the core, within the framework f strand that contains two tyrosines
and a cysteine, which participates in the intrachain disul-packing against Leu92 and Ile32, with its main chain
hydrogen bonding to Arg70O. Residues 28–30 adopt a phide bond. To control crucial aspects of receptor con-
formation, these buried framework residues were ob-type I  turn, with Ser28o hydrogen bonding to
Asp30AO2 and Thr30o1, respectively (Figure 5A). The served to make core interactions with other V residues
as well as with residues encoded within the J segmentmain chain of Ser28N,O hydrogen bonds to Arg70n	2
and to Asp30AO2. The aromatic ring of Tyr31 is sand- (Figure 7).
CDR3 comprises 11 residues (residues 93–104)wiched between Leu50, His48, and His33, leaving its
hydroxyl group pointing upward and solvent exposed. forming a loop that adopts a type II  hairpin (96–99)
at its tip and that is dominated by small residues, (FigureCDR2 comprises residues 49–54 and exhibits an ex-
tended conformation, with residues 51–54 adopting a 7). Part of this CDR loop represents one of the most
mobile regions of the TcR (Figure 2A), with a break intype IV  turn (Figures 2B, 5B, and 6). This CDR makes
predominantly polar and van der Waals contacts with the main chain electron density between residues 96
and 97 and relatively poor electron density for residuesCDR1 and with residues from the c″-d loop. Gly49O,N
hydrogen bonds to Ile32O,N. The side chain of Leu50, 94–98—a region that makes no contacts with neigh-
boring residues (Figure 7). There are three glycines (96,which is seen in two alternate conformations, packs
against the aromatic ring of Tyr31, while the backbone 97, and 102) within this CDR3 loop, where their small
Structure
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Figure 5. Ball and Stick Representation of the CDR Regions, with the Final 2Fo  Fc Electron Density Superposed in a Mesh Format
(A) CDR1; (B) CDR2; (C) CDR1; (D) CDR2.
size and flexibility might be critical to allow the correct ing a markedly different orientation within the combining
site. Pro93 at the base of the CDR3 steers the orienta-conformation of surrounding residues to optimally en-
gage the MHC-P ligand. These residues are all encoded tion of this loop away from CDR1 (Figures 2A and 7).
The residues at the base of the CDR3 (Pro93 andby the J segment and are predicted to give increased
plasticity in the recognition of the B8 complex that may Leu104) are tethered within a hydrophobic pocket, sur-
rounded by side chains of His33, Ile91, Phe106, andalso relate to the alloreactivity of this receptor.
Ser99 is also coded by the J gene segment (J52) Tyr35 (Figure 7). Notably, the public nature of the LC13
TcR is highlighted by the consistent selection of Pro93and appears to maintain the conformation of the loop,
in part, by forming a hydrogen bond with Gly96O,N (Fig- and Leu104 residues at these positions, despite the
derivation of their respective codons from the highlyure 7). This conformational freedom appears greater in
the LC13 structure in comparison with the other TcR variable V-J junctional N region and J. This observa-
tion strongly suggests that the orientation of CDR3 isstructures and may be a consequence of CDR1 adopt-
Figure 6. A Comparison of the Novel Canoni-
cal Loop Forms for CDR1, CDR2, and
CDR2 of LC13 to the Existing Canonical
Structures
Canonical loops shown as a C backbone
trace with LC13 (black), and other canonical
classes are color-coded and numbered.
There are four canonical classes for the
CDR2 loop; however, only three are shown
(one structure is not deposited in the Protein
Data Bank).
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Figure 7. Ball and Stick Stereo View Representation of the Public Sequences Selected in the LC13 TcR  Chain and the Residues with which
They Interact
The CDR3 region is subdivided into three regions according to the origin of the relevant codons: V (red), N (light blue), and J (green). The
interacting residues are color-coded gray (V) and yellow (V).
controlled by Pro93 and may be required to generate and Tyr35O	. The remainder of the J region (encoding
residues 105–116) forms the g strand (residues 110–115)the B8/FLRGRAYGL specificity, despite the fact that
Pro93 is not in a position to make direct contacts with that makes main chain hydrogen bonds with the a
strand as well as with the f strand. The main chain resi-MHC-P. Other residues encoded within the J52 seg-
ment also play important roles in CDR3 conformation dues 106–109do not make any direct hydrogen bond-
ing interaction with the N-terminal region of the a strand,(Figure 7). Importantly, many of these residues are also
buried and, therefore, not able to make direct specificity and, instead, water-mediated interactions predominate.
Thus, the contribution of many of the highly selectedcontacts with MHC-P complex, while others are highly
solvent exposed and very likely to be directly involved residues encoded by J is conformational and only indi-
rectly related to specificity. The J region also encodesin interactions that determine receptor specificity. Some
of the buried residues also appear to be critical for the two glycines (Gly107 and Gly109) that give increased
conformational freedom to this region.intersubunit interactions creating the unique dimeric 
receptor complex. For example, the CDR3 residues The  Chain
The highly conserved public sequences of the LC13 TcR100–104 form intimate contacts with CDR3 (Figure 7)
and with framework residues within the V domain (Fig- comprises residues 94–117 of the  chain encoded by
the VDJN gene segments and includes the CDR3 loopure 7). The side chain of Tyr100 (encoded by J52)
points inward, toward the core of the molecule, forming (Figure 8) CDR3 (95–107) is a relatively short loop, nine
residues in length, with a type I  turn between residuesan intersubunit aromatic cluster (Tyr48, Phe45, and
Phe33) in addition to stacking against the side chain 97 and 100 (Figure 8). The electron density for this
CDR3 loop is well ordered (data not shown). This loopof Lys103 and hydrogen bonding to the side chain of
Asp56O2. The Lys103N (J52) forms a water-mediated lies between CDR1 and CDR3 and makes contacts
with framework residues within the c strand of the Vhydrogen bond with Ser58O (Figure 7). There is also
a water-mediated interaction between Leu104O (J52) domain (Figures 1, 2A, and 8). Ser95O,N hydrogen bonds
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Figure 8. Ball and Stick Stereo View Representation of the Public Sequences Selected in the LC13 TcR  Chain and the Residues with which
They Interact
The CDR3 subdivided into three regions according to the origin of the relevant codons: V (red), D and N (light blue), and J (green). The
interacting residues are color-coded yellow (V) and gray (V). Structural superposition of a region of the identical J segment from LC13
(green) and B7 (yellow) that highlights the conformational differences.
to Ser31O,N (Figure 8). The Ser95 side chain (a V The LC13 and B7 TcRs utilize the same J segment,
BJ2S7, or TRBJ2-7, encoding residues 100–117, and,residue) is seen in two alternate conformations. In one
conformation it hydrogen bonds to Ser31O and yet, the conformation of this region is quite different in
the two structures (Figure 8). Different rotamer confor-Tyr100O via two bridging water molecules. In the other
conformation, it hydrogen bonds to Gln106O and mations are evident within the framework g strand that
result in some differing contacts within the neighboringGly97O via one water molecule. Importantly, Tyr100
and Gln106 are formed from the J2-7 gene segment residues. Larger differences are evident within the CDR
(residues 100–107), where the increased solvent expo-consistently selected by this public TcR, suggesting that
their role in CDR3 conformation is required for receptor sure translates into greater conformational freedom. For
example, Tyr100 in LC13 is 5.5 A˚ away from the corre-function. The solvent accessible side chain of the
Leu96 forms van der Waals contacts with Gly28 and sponding Tyr in B7 (Figure 8); there is a large difference
in the Glu105 rotamer between the two structures: inresidue Tyr100, encoded by J (Figure 8). Gly97O hy-
drogen bonds to Tyr100N, and Gln98 pokes directly LC13, it hydrogen bonds to Tyr107, whereas, in B7,
it curls away to form intersubunit interactions. Takeninto the CDR3 loop and hydrogen bonds to the Ser99-
O. Both Gly97 and Gln98 are encoded by a combina- together, these observations suggest that the conforma-
tion of the J segment is highly influenced by its neigh-tion of the highly selected D and N region codons
found in all LC13-like public clonotypes from unrelated boring residues.
The LC13 combining site does not contain significantindividuals. In addition to these contacts, the side chain
of J-encoded Tyr100 packs against V-encoded patches of electrostatic charge. Instead, there is a pre-
dominance of surface-exposed polar residues and aLeu96, and the hydroxyl group is fully exposed to the
solvent, like the J-encoded Tyr107O	 group, which number of hydrophobic residues that are primed to inter-
act with the B8/EBV peptide complex. Within the rela-forms a hydrogen bond with another J-encoded resi-
due, Glu105O
1, a residue that stacks against Tyr45 tively flat combining site of LC13, there is a central,
uncharged cavity lined by CDR1 residues (Tyr31 and(Figure 8). The side chain of Gln106 is buried, making
van der Waals contacts with a cluster of aromatic resi- His33), His48 encoded by V, CDR3 (Ala95) en-
coded by J, and the tip of CDR3 (Gln98 and Ala99)dues (Phe33, Tyr35, and Phe108) and a hydrogen
bond to Tyr35O	 (Figure 8). encoded by the partly germline and partly somatically
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buried and play indirect, but crucial, roles in CDR confor-
mation, intersubunit interactions, and relative orienta-
tion of the hypervariable regions. Three recent findings
suggest how biased selection of certain TcR sequences
can reflect direct specificity interactions with antigen or
indirect influences upon specificity through conforma-
tional effects.
First, TcR selection in the HLA DR-restricted immune
response to influenza hemagglutinin (HA) shows sub-
stantial conservation of acidic residues in both  and 
CDRs that interact with three lysines of the HA peptide.
This observation appears to explain the biased use of
these residues in many TcRs with this specificity. These
receptors also show biased selection of TcR residues
that make conserved MHC interactions with different
DR subtypes [32]. Interestingly, the CDR sequences that
are selectively used in the HLA DR-restricted HA re-
Figure 9. Surface Representation of the LC13 Combining Site, High- sponse all represent germline-encoded residues that
lighting the Central Cavity make crucial contributions to the TcR specificity for
Color-coding of the CDR loops is as in Figure 2B. MHC-P.
Second, restricted V13S1 and V17 CD8 TcR se-
quences in the HLA A2-restricted response to HTLV-1
created D-N region (Figure 9). This cavity is analogous Tax11-19 [6] all contain a three-amino acid sequence,
to the central cavity found in the B7 and A6 combining PG(x)G, in the CDR3 region of the V chain [6]. The B7
sites (which is negatively and positively charged, re- TCR is almost identical to VB13S1 and also contains
spectively [21, 26]) that accommodates a tyrosine from the conserved PG(x)G amino acids in the CDR3 region.
the peptide-loaded MHC. It is tempting to speculate that Importantly, these conserved residues do not directly
the deep depression at the center of the LC13 TcR would contact the Tax11-19 peptide [26]. This finding indicates
accommodate the critical tyrosine at position 7 of the that the PG(x)G amino acids in the CDR3 loop influence
EBV peptide [43]. the tertiary TCR structure and, so, indirectly contribute
to specificity, rather than directly making MHC-P inter-
Discussion actions [6]. The TcR sequences common to nearly all
LC13 clonotypes appear to involve selection of a combi-
The publicly used LC13 TcR clonotype dominates the nation of VDJN-encoded residues that control ligand
immune response to EBV EBNA 3 antigen in both acute specificity both through direct interactions with MHC-P
and persistent infection [5, 8]. We cannot rule out that as well as indirectly through conformational contributions.
nonrandom gene rearrangements [44] or neonatal reper- Third, the structure of a human  TcR shows that the
toire bias [45, 46] plays some role in selective TcR usage V domains are similar in overall structure to those of 
such as that described here; however, the involvement TCRs, but that the  TCR C domains are markedly
of all elements of both TcR  chains makes this seem different, implying the potential for different modes of
unlikely. Moreover, in heterozygous individuals who are signaling by these receptors [47]. Moreover the  V
HLA B8 and either B*4402 or B*4403, the CTL re- domain CDRs form a binding site for phosphorylated
sponse to the FLRGRAYGL determinant removes LC13- antigens, and this may explain the canonical usage of
like TcRs to avoid self-reactivity [7, 37] and expands a the V9 and V2 gene segments by phosphoantigen-
new B8-restricted, FLRGRAYGL-specific repertoire that reactive  T cell receptors [47].
uses different V, D, and J region genes, leading to new The ancient nature of EBV infection in human popula-
CDR structures in these T cells [7]. This observation tions and the high frequency of HLA B8 in Caucasians
indicates that there is a robust redundancy in the choice make it plausible that the LC13 clonotype has under-
of receptors capable of recognizing this EBV determi- gone evolutionary selection for this specificity, which is
nant. Furthermore, in some individuals, identical LC13- substantially germline encoded. It will be of great inter-
like V/V clonotypes are arrived at through different est to determine whether the highly selected structural
rearrangement events involving the V(N)(D)(N)J regions features of the LC13 TcR confer superior binding kinet-
of both TcR chains [5]. Accordingly, we believe our find- ics, ligand affinity, structural stability, or more-efficient
ings provide strong evidence that the imunodominance synapse and signaling characteristics to T cells.
of the LC13 clonotype in HLA B8, EBV individuals
results from structural properties of the  receptor.
The high-resolution structure of the LC13 TcR indicates Biological Implications
that residues encoded by the highly selected public
VDJN regions of the  and  chains play multiple roles Epstein-Barr virus (EBV) is a ubiquitous human patho-
gen, with around 90% of the population infected. Oncein controlling the TcR conformation. Some publically
selected residues are solvent exposed and in a position infected the virus is rarely cleared from the host but
contained by a vigorous cellular immune response. Theto control the MHC-P interaction by direct ligand interac-
tions. By contrast, other publicly selected residues are chronic nature of the infection results in the selection of
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high-affinity cytotoxic T lymphocytes (CTL) to a limited Table 1. Data Collection and Refinement Statistics
number of latent determinants.
Data Collection Statistics
Despite a potential repertoire of1015  T cell recep-
Temperature 100 Ktors (TcR), the HLA B8-restricted cytolytic T cell re-
X-ray source Station 14BM-C, BioCars, APSsponse to a latent antigen of EBV is strikingly limited in
Detector Quantum 4
the TcR  sequences that are selected. Even in unre- Space group P212121
lated individuals this response is dominated by a single Cell dimensions (a, b, c) (A˚) 45.8, 68.1, 160.5
highly restricted TcR  clonotype that can be present Resolution (A˚) 1.5
Total number of observations 349,805in levels up to 10% of infected individuals. We have
Number of unique observations 75,430determined the 1.5 A˚ crystal structure of one such public
Multiplicity 4.6T cell receptor (TcR) (termed LC13), representing a sig-
Data completeness (%) 91.3 (79.3)
nificant addition to the previously determined TcR struc- Number of data  2I 67.0 (33.7)
tures. The high-resolution structure highlighted the sig- I/I 8.8 (2.0)
nificant role water molecules play not only at the Rmergea (%) 7.8 (52.2)
interdomain interfaces, but also at the combining site.
Refinement Statistics
Within the hypervariable region, it is notable that, in
Nonhydrogen atomsaddition to the unique CDR3and CDR3 loops, CDR1,
Protein 3,486CDR2, and CDR2 adopt novel canonical conforma-
Water 691
tions. Consequently, the structural landscape of the Resolution (A˚) 50–1.5
LC13 antigen combining site is significantly different to Rfactorb (%) 21.5
the previously determined TcR structures and contains Rfreeb (%) 23.5
Rms deviations from idealitya deep pocket that is predicted to overlay the HLA B8-
Bond lengths (A˚) 0.006peptide complex.
Bond angles () 1.34Residues encoded by the highly selected public VDJN
Impropers () 0.76
regions of the  and  chains play multiple roles in Dihedrals () 26.28
controlling the LC13 TcR conformation. Some publicly Ramachandran plot
selected residues are solvent exposed and in a position Most-favored region (%) 89.7
Allowed region (%) 9.7to control the MHC-P interaction by direct ligand-inter-
B factors (A˚2)actions. By contrast, other publically selected residues
Average main chain 19.5are buried and play indirect, but crucial, roles in CDR
Average side chain 22.3
conformation, intersubunit interactions, and relative ori- Average water molecule 34.8
entation of the hypervariable regions. The findings sug- Rmsd of bonded Bs 1.6
gest a structural basis for the immunodominance of this
The values in parentheses are for the highest resolution bin (approxi-
clonotype in the immune response to EBV. mate interval, 0.1 A˚).
aRmerge  |Ihkl  Ihkl|/Ihkl.
Experimental Procedures bRfactor  hkl||Fo|  |Fc||/hkl |Fo| for all data, except for 3%, which
was used for the Rfree calculation.
cDNA Isolation and Construction of Expression Plasmids
RNA was prepared from LC13 T cells with Trizol (Life Technologies)
and was reverse transcribed. A DNA fragment containing the se- were grown by the hanging drop vapor diffusion technique at room
quence encoding either the LC13  or  chain was obtained by PCR temperature. The crystals were grown by mixing equal volumes of
amplification of cDNA with combinations of either the 5 primer 10 mg/ml TcR with the reservoir buffer (12%–15% PEG 8000 and
CGCCATATGAAAACCACACAGCCAAATTCA and the 3 primer CCC 200 mM NaCl [pH 6.5]). The crystals belong to space group P212121,
AAGCTTTTAGGAGCTCTCTGGGCTGGGGAAGAAG ( chain) or the with unit cell dimensions a  45.8 A˚, b  68.1 A˚, and c  160.5 A˚.
5 primer CGCCATATGGGTGTCTCCCAGTCCCCTAGG and the 3 The crystals were flash-frozen prior to data collection with 15%
primer, CCCAAGCTTTTAGTCTGCGCGCCCCCAGGCCTCGGCG glycerol as the cryoprotectant. The data were processed and scaled
CTG ( chain). Each PCR-derived  or  gene was cloned as a NdeI- with the HKL package [51]. For a summary of statistics, see Table 1.
HindIII fragment into the pET-30 expression vector (Novagen) and The structure was solved by the molecular replacement method
sequenced for verification. Translation is terminated immediately with programs from the CCP4 Suite [52]. The human B7 TcR crystal
before each of the  or  chain constant region cysteines normally structure was the search probe. Unbiased features in the initial
forming an interchain disulphide bond. The codon encoding the electron density maps confirmed the correctness of the molecular
unpaired cysteine at position 186 of the C region was changed to replacement solution.
encode alanine by site-directed mutagenesis (QuikChange; Stra- The progress of refinement was monitored by the Rfree value (3%
tagene) (see bold, underlined “A” in the Supplementary Material of the data), with neither a sigma nor a low-resolution cutoff being
available online with this article). The LC13 V chain was originally applied to the data. The structure was refined by rigid-body fitting
designated BV6S3* on the basis of a partial sequence of the V and the simulated-annealing protocol implemented in CNS (version
coding region [5]; however, complete sequencing shows the LC13 1.0) [53], interspersed with rounds of model building with the pro-
VDJ gene to be identical to BV6S2A1N1T/BD/BJ2S7 [48], or gram O [54]. Water molecules were included in the model with stan-
TRBV7-8*03; TRBD1*01; TRBJ2-7*01 in the nomenclature of the dard criteria. The final model, comprising residues 2–203 of the 
IMGT database [49]. The VJ designation is AV4S1/AJ14S3 [48], chain, 2–247 of the  chain, and 691 water molecules, has an R
or TRAV26-2*01; TRAJ52*01 [49]. The predicted amino acid se- factor of 21.5% and an Rfree of 23.5% for all reflections between 50
quence for LC13  and  chains is given in the Supplementary and 1.5 A˚. Some evidence of radiation damage encountered during
Material. the data collection may account for the slightly higher R factor and
Rfree values than were expected for this resolution. See Table 1 for
a summary of refinement statistics and model quality. Two residues,Crystallization, Data Collection, and Structure Determination
Inclusion body protein of the LC13 and LC13 chain was prepared Glu15 and Asn51, both of which are in excellent electron density,
lie within generously allowed regions of the Ramachandran plot [55].essentially as previously described [50]. Large, plate-like crystals
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Supplementary Material Sewell, A.K., O’Callaghan, C.A., Rowland-Jones, S.L., Callan,
M.F., and McMichael, A.J. (1998). Oligoclonal expansions ofThe Supplementary Material, which includes tabulated lists of direct
variable/variable domain contacts (Table S1), direct constant do- CD8() T cells in chronic HIV infection are antigen specific. J.
Exp. Med. 188, 785–790.main/constant domain contacts (Table S2), and interdomain water-
mediated contacts (Table S3), pairwise superposition statistics (Ta- 12. Oksenberg, J.R., Panzara, M.A., Begovich, A.B., Mitchell, D.,
Erlich, H.A., Murray, R.S., Shimonkevitz, R., Sherritt, M., Roth-ble S4), and the sequences of the  and  chain, respectively, with
secondary structure assignments displayed above the sequence, bard, J., Bernard, C.C., et al. (1993). Selection for T-cell receptor
V beta-D beta-J beta gene rearrangements with specificity forcan be found online at http://images.cellpress.com/supmat/
supmatin.htm. a myelin basic protein peptide in brain lesions of multiple sclero-
sis. Nature 362, 68–70.
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